Table 6.
Predictive impact of the AgNOR variables within subgroups of patients with different pRb/p53 status investigated by the log rank test
| n | % DFS | χ2 | p Value | |
| pRb− p53− | ||||
| AgNOR area <5 μm2 | 203 | 77.83 | 2.39 | 0.1224 |
| AgNOR area >5 μm2 | 26 | 65.38 | ||
| pRb+ p53+ | ||||
| AgNOR area <5 μm2 | 15 | 46.67 | 0 | 0.9735 |
| AgNOR area >5 μm2 | 26 | 50 | ||
| pRb− p53+ | ||||
| AgNOR area <5 μm2 | 13 | 53.85 | 0.32 | 0.5702 |
| AgNOR area >5 μm2 | 14 | 64.29 | ||
| pRb+ p53− | ||||
| AgNOR area <5 μm2 | 18 | 61.11 | 1.52 | 0.2184 |
| AgNOR area >5 μm2 | 20 | 40 |
AgNOR, argyrophilic nucleolar organiser region; DFS, disease free survival.